drugset / Trial / NCT03634995

An Investigational Study to Evaluate the Effects of Experimental Medication BMS-986256 in Healthy Participants

NCT03634995

Phase 1 Completed 118 enrolled Bristol-Myers Squibb
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effects of the experimental medication BMS-986256 in healthy participants.

Timeline

Start
2018-08-14
Primary completion
2019-10-09
Completion
2019-10-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Afimetoran Small molecule

Indications

No indication recorded.